The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Potent heterocyclic ligands for human complement c3a receptor.EBI
The University of Queensland
Discovery of new C3aR ligands. Part 2: amino-piperidine derivatives.EBI
Ucb Pharma
Discovery of new C3aR ligands. Part 1: arginine derivatives.EBI
Ucb Pharma
De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation.EBI
Princeton University
Selective hexapeptide agonists and antagonists for human complement C3a receptor.EBI
The University of Queensland
Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.EBI
The University of Queensland
Design, synthesis, and biological activity of diiminoisoindolines as complement component 3a antagonists.EBI
The R. W. Johnson Pharmaceutical Research Institute
Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity.EBI
TBA
Potent complement C3a receptor agonists derived from oxazole amino acids: Structure-activity relationships.EBI
The University of Queensland
Chemical Approaches to Modulating Complement-Mediated Diseases.EBI
The University of Queensland